188 related articles for article (PubMed ID: 36281920)
1. Calcium‑dependent activation of PHEX, MEPE and DMP1 in osteocytes.
Donmez BO; Karagur ER; Donmez AC; Choi J; Akkus O
Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36281920
[TBL] [Abstract][Full Text] [Related]
2. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
Rowe PS
Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
[TBL] [Abstract][Full Text] [Related]
4. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
[TBL] [Abstract][Full Text] [Related]
6. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
[TBL] [Abstract][Full Text] [Related]
7. Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.
Boukpessi T; Gaucher C; Léger T; Salmon B; Le Faouder J; Willig C; Rowe PS; Garabédian M; Meilhac O; Chaussain C
Am J Pathol; 2010 Aug; 177(2):803-12. PubMed ID: 20581062
[TBL] [Abstract][Full Text] [Related]
8. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.
Addison WN; Nakano Y; Loisel T; Crine P; McKee MD
J Bone Miner Res; 2008 Oct; 23(10):1638-49. PubMed ID: 18597632
[TBL] [Abstract][Full Text] [Related]
9. Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.
Coyac BR; Hoac B; Chafey P; Falgayrac G; Slimani L; Rowe PS; Penel G; Linglart A; McKee MD; Chaussain C; Bardet C
J Dent Res; 2018 Feb; 97(2):184-191. PubMed ID: 28880715
[TBL] [Abstract][Full Text] [Related]
10. Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers.
Welldon KJ; Findlay DM; Evdokiou A; Ormsby RT; Atkins GJ
Mol Cell Endocrinol; 2013 Aug; 376(1-2):85-92. PubMed ID: 23791847
[TBL] [Abstract][Full Text] [Related]
11. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
[TBL] [Abstract][Full Text] [Related]
12. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).
Rowe PS; Garrett IR; Schwarz PM; Carnes DL; Lafer EM; Mundy GR; Gutierrez GE
Bone; 2005 Jan; 36(1):33-46. PubMed ID: 15664000
[TBL] [Abstract][Full Text] [Related]
13. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.
Lorenz-Depiereux B; Bastepe M; Benet-Pagès A; Amyere M; Wagenstaller J; Müller-Barth U; Badenhoop K; Kaiser SM; Rittmaster RS; Shlossberg AH; Olivares JL; Loris C; Ramos FJ; Glorieux F; Vikkula M; Jüppner H; Strom TM
Nat Genet; 2006 Nov; 38(11):1248-50. PubMed ID: 17033625
[TBL] [Abstract][Full Text] [Related]
14. Molecular regulation of matrix extracellular phosphoglycoprotein expression by bone morphogenetic protein-2.
Cho YD; Yoon WJ; Woo KM; Baek JH; Lee G; Cho JY; Ryoo HM
J Biol Chem; 2009 Sep; 284(37):25230-40. PubMed ID: 19617624
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MEPE cleavage by Phex.
Guo R; Rowe PS; Liu S; Simpson LG; Xiao ZS; Quarles LD
Biochem Biophys Res Commun; 2002 Sep; 297(1):38-45. PubMed ID: 12220505
[TBL] [Abstract][Full Text] [Related]
16. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.
Pereira RC; Juppner H; Azucena-Serrano CE; Yadin O; Salusky IB; Wesseling-Perry K
Bone; 2009 Dec; 45(6):1161-8. PubMed ID: 19679205
[TBL] [Abstract][Full Text] [Related]
17. The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.
Rowe PS
Cell Biochem Funct; 2012 Jul; 30(5):355-75. PubMed ID: 22573484
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE.
Kulkarni RN; Bakker AD; Everts V; Klein-Nulend J
Calcif Tissue Int; 2010 Nov; 87(5):461-8. PubMed ID: 20725825
[TBL] [Abstract][Full Text] [Related]
19. Do osteocytes contribute to phosphate homeostasis?
Feng JQ; Ye L; Schiavi S
Curr Opin Nephrol Hypertens; 2009 Jul; 18(4):285-91. PubMed ID: 19448536
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis.
Qin C; Baba O; Butler WT
Crit Rev Oral Biol Med; 2004 Jun; 15(3):126-36. PubMed ID: 15187031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
